Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin 8% vs Lidocaine 5% in South Asian Males With Diabetic Neuropathy
NCT04238208Phase 4Completed
- Sponsor
- Hospital Universitari Parc Taulí
- Start
- Jan 2019
- Primary completion
- Dec 2019
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of capsaicin 8% patch in diabetic peripheral neuropathy (DPN), sponsored by Hospital Universitari Parc Taulí. Started Jan 2019; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04238208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04238208.